|
G |
Abcc8 |
ATP binding cassette subfamily C member 8 |
multiple interactions |
EXP |
ABCC8 protein inhibits the reaction [Acetylcholine promotes the reaction [KCNJ8 protein results in increased transport of Potassium]] |
CTD |
PMID:15894309 |
|
NCBI chr 1:96,598,568...96,679,563
Ensembl chr 1:96,598,647...96,679,510
|
|
G |
Ache |
acetylcholinesterase |
increases hydrolysis affects abundance multiple interactions increases abundance increases activity |
ISO EXP |
ACHE protein results in increased hydrolysis of Acetylcholine ACHE protein affects the abundance of Acetylcholine [Organophosphorus Compounds results in decreased activity of ACHE protein] which results in increased abundance of Acetylcholine; Acetylcholine inhibits the reaction [ACHE protein results in increased hydrolysis of Acetylthiocholine]; Atropine inhibits the reaction [[Organophosphorus Compounds results in decreased activity of ACHE protein] which results in increased abundance of Acetylcholine] ACHE gene mutant form results in increased abundance of Acetylcholine Acetylcholine results in increased activity of ACHE protein [Botulinum Toxins, Type A results in increased expression of and results in increased activity of ACHE protein] which results in decreased abundance of Acetylcholine; [Soman results in decreased activity of ACHE protein] which results in increased abundance of Acetylcholine; Rivastigmine inhibits the reaction [[Botulinum Toxins, Type A results in increased expression of and results in increased activity of ACHE protein] which results in decreased abundance of Acetylcholine] |
CTD |
PMID:18602908 PMID:19100287 PMID:19818744 PMID:20105433 PMID:20396698 PMID:22542756 PMID:23047027 PMID:31247192 PMID:37507053 More...
|
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Adcy5 |
adenylate cyclase 5 |
increases response to substance |
ISO |
ADCY5 protein results in increased susceptibility to Acetylcholine |
CTD |
PMID:12869393 |
|
NCBI chr11:65,471,612...65,618,877
Ensembl chr11:65,471,612...65,618,974
|
|
G |
Adora2a |
adenosine A2a receptor |
increases response to substance multiple interactions |
EXP |
ADORA2A protein results in increased susceptibility to Acetylcholine ZM 241385 inhibits the reaction [ADORA2A protein results in increased susceptibility to Acetylcholine] |
CTD |
PMID:16616212 |
|
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
|
|
G |
Adra2b |
adrenoceptor alpha 2B |
multiple interactions |
ISO |
ADRA2B protein affects the susceptibility to [Phenylephrine co-treated with Acetylcholine] |
CTD |
PMID:16815979 |
|
NCBI chr 3:114,585,174...114,589,220
Ensembl chr 3:114,585,169...114,589,355
|
|
G |
Agt |
angiotensinogen |
multiple interactions decreases response to substance |
ISO |
ATOX1 protein inhibits the reaction [AGT protein modified form results in decreased susceptibility to Acetylcholine]; ATP7A mutant form inhibits the reaction [AGT protein results in increased susceptibility to Acetylcholine]; SB 203580 inhibits the reaction [AGT protein modified form results in decreased susceptibility to Acetylcholine]; tempol inhibits the reaction [ATP7A mutant form inhibits the reaction [AGT protein results in increased susceptibility to Acetylcholine]]; tempol promotes the reaction [ATOX1 protein inhibits the reaction [AGT protein modified form results in decreased susceptibility to Acetylcholine]] AGT protein modified form results in decreased susceptibility to Acetylcholine; AGT protein results in decreased susceptibility to Acetylcholine |
CTD |
PMID:18174886 PMID:18768397 PMID:21289285 PMID:22753205 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Alb |
albumin |
multiple interactions |
ISO |
[ALB protein co-treated with Particulate Matter] results in increased susceptibility to Acetylcholine; ALB protein promotes the reaction [Particulate Matter results in increased susceptibility to Acetylcholine] |
CTD |
PMID:30953400 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
multiple interactions |
ISO |
[ALOX15 protein affects the metabolism of Arachidonic Acid] which affects the susceptibility to Acetylcholine |
CTD |
PMID:21193584 |
|
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
|
|
G |
Apoe |
apolipoprotein E |
affects response to substance decreases response to substance |
ISO |
APOE protein affects the susceptibility to Acetylcholine APOE gene mutant form results in decreased susceptibility to Acetylcholine |
CTD |
PMID:11397713 PMID:17899169 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions decreases secretion |
ISO EXP |
[IL1B protein co-treated with APP protein] results in increased secretion of Acetylcholine; IL1B protein inhibits the reaction [APP protein results in decreased secretion of Acetylcholine] APP protein modified form inhibits the reaction [Nicotine results in increased secretion of Acetylcholine]; spiro(imidazo-(1,2-a)pyridine-3,2-indan)-2(3H)-one inhibits the reaction [APP protein modified form inhibits the reaction [Nicotine results in increased secretion of Acetylcholine]] GW 501516 inhibits the reaction [APP gene mutant form results in decreased susceptibility to Acetylcholine] |
CTD |
PMID:16122837 PMID:16474004 PMID:22886847 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
increases response to substance |
ISO |
ASS1 protein results in increased susceptibility to Acetylcholine |
CTD |
PMID:25033204 |
|
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atox1 |
antioxidant 1 copper chaperone |
increases response to substance multiple interactions |
ISO |
ATOX1 protein results in increased susceptibility to Acetylcholine ATOX1 protein inhibits the reaction [AGT protein modified form results in decreased susceptibility to Acetylcholine]; tempol promotes the reaction [ATOX1 protein inhibits the reaction [AGT protein modified form results in decreased susceptibility to Acetylcholine]] |
CTD |
PMID:22753205 |
|
NCBI chr10:39,564,855...39,579,892
Ensembl chr10:39,564,857...39,579,950
|
|
G |
Atp7a |
ATPase copper transporting alpha |
multiple interactions |
ISO |
ATP7A mutant form inhibits the reaction [AGT protein results in increased susceptibility to Acetylcholine]; tempol inhibits the reaction [ATP7A mutant form inhibits the reaction [AGT protein results in increased susceptibility to Acetylcholine]] |
CTD |
PMID:18768397 |
|
NCBI chr X:71,094,144...71,201,550
Ensembl chr X:71,094,202...71,198,354
|
|
G |
Bche |
butyrylcholinesterase |
increases degradation multiple interactions |
ISO |
BCHE protein results in increased degradation of Acetylcholine Acetylcholine inhibits the reaction [BCHE protein results in increased hydrolysis of benzoylthiocholine]; Acetylcholine inhibits the reaction [Tripelennamine results in decreased activity of BCHE protein] |
CTD |
PMID:236606 PMID:16020944 PMID:31247192 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
multiple interactions increases response to substance |
EXP |
calcitonin gene-related peptide (8-37) inhibits the reaction [CALCA protein results in increased susceptibility to Acetylcholine] |
CTD |
PMID:16616212 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Cav1 |
caveolin 1 |
multiple interactions |
ISO |
Sodium, Dietary affects the reaction [CAV1 protein affects the susceptibility to Acetylcholine] |
CTD |
PMID:18178722 |
|
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
increases activity multiple interactions affects binding |
ISO EXP |
Acetylcholine results in increased activity of CHRM1 protein [Acetylcholine results in increased activity of CHRM1 protein] which results in increased abundance of Calcium; Acetylcholine binds to and results in increased activity of CHRM1 protein; brucine analog affects the reaction [Acetylcholine binds to CHRM1 protein]; brucine promotes the reaction [Acetylcholine binds to CHRM1 protein]; brucine promotes the reaction [Acetylcholine results in increased activity of CHRM1 protein]; Endocannabinoids promotes the reaction [Acetylcholine binds to and results in increased activity of CHRM1 protein]; KT 5720 promotes the reaction [Acetylcholine binds to CHRM1 protein]; Quinuclidinyl Benzilate inhibits the reaction [brucine promotes the reaction [Acetylcholine results in increased activity of CHRM1 protein]] Pregnenolone inhibits the reaction [Acetylcholine binds to CHRM1 protein]; Progesterone inhibits the reaction [Acetylcholine binds to CHRM1 protein]; Propofol inhibits the reaction [Acetylcholine results in increased activity of CHRM1 protein] Acetylcholine binds to CHRM1 protein; CHRM1 protein binds to Acetylcholine |
CTD |
PMID:9224827 PMID:9495826 PMID:10069518 PMID:10101037 PMID:10860942 PMID:11527950 PMID:14534362 PMID:15900516 PMID:30102254 PMID:31830555 More...
|
|
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
multiple interactions affects binding |
ISO |
Acetylcholine binds to and results in increased activity of CHRM2 protein; brucine analog affects the reaction [Acetylcholine binds to CHRM2 protein]; eburnamonine promotes the reaction [Acetylcholine binds to CHRM2 protein]; N-chloromethylbrucine inhibits the reaction [Acetylcholine results in increased activity of CHRM2 protein] Acetylcholine binds to CHRM2 protein; CHRM2 protein binds to Acetylcholine |
CTD |
PMID:9224827 PMID:10069518 PMID:10101037 |
|
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
|
|
G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
increases activity multiple interactions affects binding increases response to substance |
EXP ISO |
Acetylcholine results in increased activity of CHRM3 protein Pregnenolone inhibits the reaction [Acetylcholine binds to CHRM3 protein]; Progesterone inhibits the reaction [Acetylcholine binds to CHRM3 protein]; WIN 62577 analog inhibits the reaction [Acetylcholine binds to CHRM3 protein]; WIN 62577 promotes the reaction [Acetylcholine binds to CHRM3 protein] Acetylcholine binds to and results in increased activity of CHRM3 protein; brucine analog affects the reaction [Acetylcholine binds to CHRM3 protein]; brucine N-oxide promotes the reaction [Acetylcholine binds to CHRM3 protein]; brucine promotes the reaction [Acetylcholine binds to CHRM3 protein]; N-chloromethylbrucine promotes the reaction [Acetylcholine binds to CHRM3 protein]; N-chloromethylbrucine promotes the reaction [Acetylcholine results in increased activity of CHRM3 protein] Acetylcholine binds to CHRM3 protein; CHRM3 protein binds to Acetylcholine CHRM3 protein results in increased susceptibility to Acetylcholine |
CTD |
PMID:9224827 PMID:9495826 PMID:10069518 PMID:10101037 PMID:11755166 PMID:12435818 PMID:15900516 PMID:15964566 PMID:19407017 PMID:31830555 More...
|
|
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
|
|
G |
Chrm4 |
cholinergic receptor, muscarinic 4 |
multiple interactions affects binding |
ISO |
[WIN 62577 co-treated with Quinuclidinyl Benzilate] inhibits the reaction [Acetylcholine binds to CHRM4 protein]; Acetylcholine binds to and results in increased activity of CHRM4 protein; brucine analog affects the reaction [Acetylcholine binds to CHRM4 protein]; brucine N-oxide promotes the reaction [Acetylcholine binds to CHRM4 protein]; brucine N-oxide promotes the reaction [Acetylcholine results in increased activity of CHRM4 protein]; eburnamonine promotes the reaction [Acetylcholine binds to CHRM4 protein] Acetylcholine binds to CHRM4 protein; CHRM4 protein binds to Acetylcholine |
CTD |
PMID:9224827 PMID:9495826 PMID:10069518 PMID:10101037 PMID:16709648 |
|
NCBI chr 3:77,893,425...77,901,166
Ensembl chr 3:77,893,425...77,901,159
|
|
G |
Chrm5 |
cholinergic receptor, muscarinic 5 |
affects response to substance decreases response to substance multiple interactions increases activity |
ISO |
CHRM5 protein affects the susceptibility to Acetylcholine CHRM5 protein mutant form results in decreased susceptibility to Acetylcholine Atropine inhibits the reaction [Acetylcholine results in increased activity of CHRM5 protein] |
CTD |
PMID:14607263 PMID:31323226 |
|
NCBI chr 3:99,284,846...99,337,252
Ensembl chr 3:99,284,846...99,337,252
|
|
G |
Chrna1 |
cholinergic receptor nicotinic alpha 1 subunit |
multiple interactions |
ISO EXP |
Acetylcholine binds to and results in increased activity of [CHRNA1 protein binds to CHRNA1 protein binds to CHRNB1 protein binds to CHRND protein binds to CHRNE protein]; Acetylcholine binds to and results in increased activity of [CHRNA1 protein binds to CHRNA1 protein binds to CHRNB1 protein binds to CHRNG protein binds to CHRND protein]; Acetylcholine results in increased activity of [CHRNA1 protein binds to CHRNB1 protein binds to CHRNE protein binds to CHRND protein] Acetylcholine binds to and results in increased activity of [CHRNA1 protein binds to CHRNA1 protein binds to CHRNB1 protein binds to CHRND protein binds to CHRNE protein]; Acetylcholine binds to and results in increased activity of [CHRNA1 protein binds to CHRNA1 protein binds to CHRNB1 protein binds to CHRNG protein binds to CHRND protein]; Acetylcholine results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]; LYNX1 protein promotes the reaction [Acetylcholine results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]]; LYPD1 protein promotes the reaction [Acetylcholine results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]] |
CTD |
PMID:16931985 PMID:19619141 PMID:22461452 |
|
NCBI chr 3:58,454,763...58,469,832
Ensembl chr 3:58,454,744...58,469,840
|
|
G |
Chrna10 |
cholinergic receptor nicotinic alpha 10 subunit |
multiple interactions |
ISO |
2-xylene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA9 protein binds to CHRNA10 protein]]; 3-xylene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA9 protein binds to CHRNA10 protein]]; 4-xylene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA9 protein binds to CHRNA10 protein]]; Acetylcholine results in increased activity of [CHRNA9 protein binds to CHRNA10 protein]; ethylbenzene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA9 protein binds to CHRNA10 protein]] |
CTD |
PMID:18602458 |
|
NCBI chr 1:156,487,279...156,494,277
Ensembl chr 1:156,487,279...156,491,476
|
|
G |
Chrna2 |
cholinergic receptor nicotinic alpha 2 subunit |
multiple interactions affects response to substance |
ISO EXP |
1-Butanol affects the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]; 1-Propanol promotes the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]; 2-butanol affects the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]; 2-Propanol promotes the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]; Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]; Acetylcholine results in increased activity of [CHRNB4 protein binds to CHRNA2 protein]; crotonyl alcohol inhibits the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]; isobutyl alcohol affects the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]; n-pentanol inhibits the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]; tert-Butyl Alcohol inhibits the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]] CHRNA2 gene mutant form affects the susceptibility to Acetylcholine Acetylcholine binds to and results in increased activity of [CHRNB2 protein binds to CHRNA2 protein]; Acetylcholine binds to and results in increased activity of [CHRNB4 protein binds to CHRNA2 protein]; Tubocurarine inhibits the reaction [Acetylcholine binds to and results in increased activity of [CHRNB2 protein binds to CHRNA2 protein]]; Tubocurarine promotes the reaction [Acetylcholine binds to and results in increased activity of [CHRNB4 protein binds to CHRNA2 protein]] acetylcholine affects binding competes with [Epibatidine binds to Chrna2 protein] |
CTD RGD |
PMID:7808438 PMID:9454827 PMID:11821649 PMID:19383498 PMID:15016836 |
RGD:2303194 |
NCBI chr15:40,342,317...40,358,601
Ensembl chr15:40,342,317...40,358,601
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
multiple interactions |
ISO EXP |
4-nonylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]; 4-nonylphenol promotes the reaction [Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]]; 4-octylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]; Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]; Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]; Acetylcholine results in increased activity of [CHRNB4 protein binds to CHRNA3 protein]; Atracurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Atracurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]]; bisphenol A inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]; bisphenol A promotes the reaction [Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]]; cisatracurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; cisatracurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]]; Diethylstilbestrol inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]; Diethylstilbestrol promotes the reaction [Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]]; Estradiol inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]; Estradiol promotes the reaction [Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]]; Ethinyl Estradiol inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]; Ethinyl Estradiol inhibits the reaction [Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]]; Mivacurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Mivacurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]]; Pancuronium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Pancuronium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]]; Rocuronium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Rocuronium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]]; Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]; Tetrachloroethylene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Toluene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Tubocurarine inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Tubocurarine inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]]; Vecuronium Bromide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Vecuronium Bromide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]] [Mercuric Chloride co-treated with Acetylcholine] affects the activity of [CHRNA3 protein binds to CHRNB4 protein]; Acetylcholine binds to and results in increased activity of [CHRNB2 protein binds to CHRNA3 protein]; Acetylcholine binds to and results in increased activity of [CHRNB4 protein binds to CHRNA3 protein]; Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]; Tetrachloroethylene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Toluene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Tubocurarine inhibits the reaction [Acetylcholine binds to and results in increased activity of [CHRNB2 protein binds to CHRNA3 protein]]; Tubocurarine promotes the reaction [Acetylcholine binds to and results in increased activity of [CHRNB4 protein binds to CHRNA3 protein]] Acetylcholine affects binding [Epibatidine binds to Chrna3 protein] |
CTD RGD |
PMID:7808438 PMID:9454827 PMID:11711029 PMID:12130716 PMID:15885267 PMID:16931985 PMID:34628512 PMID:15016836 More...
|
RGD:2303194 |
NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
multiple interactions increases response to substance affects binding |
ISO EXP |
1-Butanol affects the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; 2,4,2',4'-tetrachlorobiphenyl inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; 3,5-dibromo-2-(2,4-dibromophenoxy)phenol inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; 4-nonylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; 4-octylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; [3,5-dibromo-2-(2,4-dibromophenoxy)phenol co-treated with 2,4,2',4'-tetrachlorobiphenyl] inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; [Estradiol co-treated with Acetylcholine] results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; [Ethinyl Estradiol co-treated with Acetylcholine] results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; [Progesterone co-treated with Acetylcholine] results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]; Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]; Acetylcholine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]; Acetylcholine results in increased activity of [CHRNB4 protein binds to CHRNA4 protein]; Aluminum Hydroxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; antimony trioxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Atracurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Atropine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Bentonite inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; bisphenol A inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; cisatracurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; clothianidin promotes the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; decabromobiphenyl ether inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; desformylflustrabromine promotes the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Dichlorvos inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Diethylstilbestrol inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Ethinyl Estradiol promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Fire Trol 934 inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Flame Retardants inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Flame Retardants inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Galantamine inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; imidacloprid inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Magnesium Hydroxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Mivacurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Pancuronium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Physostigmine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Rivastigmine inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Rocuronium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Scopolamine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Tacrine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; tetrabromobisphenol A inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; tetrabromobisphenol A inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Tetrachloroethylene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Toluene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; triphenyl phosphate inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Tubocurarine inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Tubocurarine inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Tubocurarine inhibits the reaction [Ethinyl Estradiol promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]]; Vecuronium Bromide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] CHRNA4 protein mutant form results in increased susceptibility to Acetylcholine Acetylcholine analog binds to [CHRNA4 protein binds to CHRNB2 protein]; Acetylcholine binds to [CHRNA4 protein binds to CHRNB2 protein] [CHRNA4 protein co-treated with CHRNB2 protein mutant form] inhibits the reaction [Calcium results in increased susceptibility to Acetylcholine]; [CHRNA4 protein co-treated with CHRNB2 protein] affects the reaction [Barium results in increased susceptibility to Acetylcholine]; [CHRNA4 protein co-treated with CHRNB2 protein] affects the reaction [Calcium results in increased susceptibility to Acetylcholine]; [CHRNA4 protein co-treated with CHRNB2 protein] affects the susceptibility to Acetylcholine; [CHRNA4 protein mutant form co-treated with CHRNB2 protein] inhibits the reaction [Barium results in increased susceptibility to Acetylcholine]; [CHRNA4 protein mutant form co-treated with CHRNB2 protein] inhibits the reaction [Calcium results in increased susceptibility to Acetylcholine]; [Ethinyl Estradiol co-treated with Acetylcholine] results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; [Mercuric Chloride co-treated with Acetylcholine] affects the activity of [CHRNA4 protein binds to CHRNB2 protein]; [Mercuric Chloride co-treated with Acetylcholine] affects the activity of [CHRNA4 protein binds to CHRNB4 protein]; [pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine; Acetylcholine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Dihydro-beta-Erythroidine inhibits the reaction [[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine]; Excitatory Amino Acid Antagonists inhibits the reaction [[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine]; FG 9041 inhibits the reaction [[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine]; Mecamylamine inhibits the reaction [[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine]; Tetrachloroethylene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Toluene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Urethane promotes the reaction [Acetylcholine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] acetylcholine affects binding to Chrna4 protein; acetylcholine competes with [Epibatidine binds to Chrna4 protein] |
CTD RGD |
PMID:9454827 PMID:11517245 PMID:11711029 PMID:11812690 PMID:12130716 PMID:12604691 PMID:12754307 PMID:14645658 PMID:15733544 PMID:15885267 PMID:16339034 PMID:16931985 PMID:18385335 PMID:19252481 PMID:20132834 PMID:20861069 PMID:21538459 PMID:21905680 PMID:22547355 PMID:22750351 PMID:34628512 PMID:15016836 More...
|
RGD:2303194 |
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrna7 |
cholinergic receptor nicotinic alpha 7 subunit |
multiple interactions increases activity increases response to substance |
EXP ISO |
1,2-linoleoylphosphatidylcholine promotes the reaction [Acetylcholine results in increased activity of CHRNA7 protein]; Acetylcholine affects the reaction [iodo-alpha-bungarotoxin binds to CHRNA7 protein]; Bungarotoxins inhibits the reaction [Acetylcholine results in increased activity of CHRNA7 protein]; methyllycaconitine inhibits the reaction [Acetylcholine results in increased activity of CHRNA7 protein]; Tetrachloroethylene inhibits the reaction [Acetylcholine results in increased activity of CHRNA7 protein]; Toluene inhibits the reaction [Acetylcholine results in increased activity of CHRNA7 protein] 1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)urea promotes the reaction [Acetylcholine results in increased activity of CHRNA7 protein]; [Acetylcholine results in increased activity of CHRNA7 protein] which results in increased uptake of Calcium; Acetylcholine binds to and results in increased activity of CHRNA7 protein; Atracurium inhibits the reaction [Acetylcholine results in increased activity of CHRNA7 protein]; beta-thujone inhibits the reaction [Acetylcholine results in increased activity of CHRNA7 protein]; Bungarotoxins inhibits the reaction [Acetylcholine results in increased activity of CHRNA7 protein]; cisatracurium inhibits the reaction [Acetylcholine results in increased activity of CHRNA7 protein]; desformylflustrabromine inhibits the reaction [Acetylcholine results in increased activity of CHRNA7 protein]; Mivacurium inhibits the reaction [Acetylcholine results in increased activity of CHRNA7 protein]; N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Acetylcholine results in increased activity of CHRNA7 protein]; Pancuronium inhibits the reaction [Acetylcholine results in increased activity of CHRNA7 protein]; Rocuronium inhibits the reaction [Acetylcholine results in increased activity of CHRNA7 protein]; Tetrachloroethylene inhibits the reaction [Acetylcholine results in increased activity of CHRNA7 protein]; Toluene inhibits the reaction [Acetylcholine results in increased activity of CHRNA7 protein]; Tubocurarine inhibits the reaction [Acetylcholine results in increased activity of CHRNA7 protein]; Vecuronium Bromide inhibits the reaction [Acetylcholine results in increased activity of CHRNA7 protein] CHRNA7 protein mutant form results in increased susceptibility to Acetylcholine |
CTD |
PMID:10082212 PMID:12626641 PMID:15885267 PMID:16931985 PMID:19100751 PMID:19448648 PMID:20132834 PMID:21051662 PMID:21905680 PMID:28395994 PMID:29191791 More...
|
|
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
|
|
G |
Chrna9 |
cholinergic receptor nicotinic alpha 9 subunit |
multiple interactions |
ISO |
2-xylene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA9 protein binds to CHRNA10 protein]]; 3-xylene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA9 protein binds to CHRNA10 protein]]; 4-xylene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA9 protein binds to CHRNA10 protein]]; Acetylcholine results in increased activity of [CHRNA9 protein binds to CHRNA10 protein]; ethylbenzene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA9 protein binds to CHRNA10 protein]] |
CTD |
PMID:18602458 |
|
NCBI chr14:42,235,218...42,241,939
Ensembl chr14:42,235,226...42,242,192
|
|
G |
Chrnb1 |
cholinergic receptor nicotinic beta 1 subunit |
multiple interactions |
ISO EXP |
Acetylcholine binds to and results in increased activity of [CHRNA1 protein binds to CHRNA1 protein binds to CHRNB1 protein binds to CHRND protein binds to CHRNE protein]; Acetylcholine binds to and results in increased activity of [CHRNA1 protein binds to CHRNA1 protein binds to CHRNB1 protein binds to CHRNG protein binds to CHRND protein]; Acetylcholine results in increased activity of [CHRNA1 protein binds to CHRNB1 protein binds to CHRNE protein binds to CHRND protein] |
CTD |
PMID:16931985 PMID:22461452 |
|
NCBI chr10:54,501,096...54,516,418
Ensembl chr10:54,501,093...54,516,345
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions affects binding |
ISO EXP |
1-Butanol affects the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; 2,4,2',4'-tetrachlorobiphenyl inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; 3,5-dibromo-2-(2,4-dibromophenoxy)phenol inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; 4-nonylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; 4-octylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; [3,5-dibromo-2-(2,4-dibromophenoxy)phenol co-treated with 2,4,2',4'-tetrachlorobiphenyl] inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; [Estradiol co-treated with Acetylcholine] results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; [Ethinyl Estradiol co-treated with Acetylcholine] results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; [Progesterone co-treated with Acetylcholine] results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]; Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]; Acetylcholine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]; Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]; Aluminum Hydroxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; antimony trioxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Atracurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Atracurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Atropine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Bentonite inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; bisphenol A inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; cisatracurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; cisatracurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; clothianidin promotes the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; decabromobiphenyl ether inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; desformylflustrabromine promotes the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Dichlorvos inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Diethylstilbestrol inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Ethinyl Estradiol promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Fire Trol 934 inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Flame Retardants inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Flame Retardants inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Galantamine inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; imidacloprid inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Magnesium Hydroxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Mivacurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Mivacurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Pancuronium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Pancuronium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Physostigmine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Rivastigmine inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Rocuronium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Rocuronium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Scopolamine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Tacrine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; tetrabromobisphenol A inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; tetrabromobisphenol A inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Tetrachloroethylene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Tetrachloroethylene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Toluene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Toluene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; triphenyl phosphate inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Tubocurarine inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Tubocurarine inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Tubocurarine inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Tubocurarine inhibits the reaction [Ethinyl Estradiol promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]]; Vecuronium Bromide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Vecuronium Bromide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] Acetylcholine analog binds to [CHRNA4 protein binds to CHRNB2 protein]; Acetylcholine binds to [CHRNA4 protein binds to CHRNB2 protein] [CHRNA4 protein co-treated with CHRNB2 protein mutant form] inhibits the reaction [Calcium results in increased susceptibility to Acetylcholine]; [CHRNA4 protein co-treated with CHRNB2 protein] affects the reaction [Barium results in increased susceptibility to Acetylcholine]; [CHRNA4 protein co-treated with CHRNB2 protein] affects the reaction [Calcium results in increased susceptibility to Acetylcholine]; [CHRNA4 protein co-treated with CHRNB2 protein] affects the susceptibility to Acetylcholine; [CHRNA4 protein mutant form co-treated with CHRNB2 protein] inhibits the reaction [Barium results in increased susceptibility to Acetylcholine]; [CHRNA4 protein mutant form co-treated with CHRNB2 protein] inhibits the reaction [Calcium results in increased susceptibility to Acetylcholine]; [Ethinyl Estradiol co-treated with Acetylcholine] results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; [Mercuric Chloride co-treated with Acetylcholine] affects the activity of [CHRNA4 protein binds to CHRNB2 protein]; [pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine; Acetylcholine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Acetylcholine binds to and results in increased activity of [CHRNB2 protein binds to CHRNA2 protein]; Acetylcholine binds to and results in increased activity of [CHRNB2 protein binds to CHRNA3 protein]; Acetylcholine results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]; Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]; Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Acetylcholine results in increased activity of [NACHRA8 protein co-treated with CHRNB2 protein]; Acetylcholine results in increased activity of [NACHRALPHA1 protein co-treated with CHRNB2 protein]; Acetylcholine results in increased activity of [NACHRALPHA1 protein co-treated with NACHRALPHA2 protein co-treated with CHRNB2 protein]; Acetylcholine results in increased activity of [NACHRALPHA2 protein co-treated with CHRNB2 protein]; Bungarotoxins inhibits the reaction [Acetylcholine results in increased activity of [NACHRALPHA1 protein co-treated with CHRNB2 protein]]; Bungarotoxins inhibits the reaction [Acetylcholine results in increased activity of [NACHRALPHA1 protein co-treated with NACHRALPHA2 protein co-treated with CHRNB2 protein]]; Bungarotoxins inhibits the reaction [Acetylcholine results in increased activity of [NACHRALPHA2 protein co-treated with CHRNB2 protein]]; Dihydro-beta-Erythroidine inhibits the reaction [[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine]; Excitatory Amino Acid Antagonists inhibits the reaction [[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine]; FG 9041 inhibits the reaction [[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine]; LYNX1 protein promotes the reaction [Acetylcholine results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]]; LYPD1 protein promotes the reaction [Acetylcholine results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]]; Mecamylamine inhibits the reaction [[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine]; Tetrachloroethylene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Tetrachloroethylene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Toluene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Toluene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Tubocurarine inhibits the reaction [Acetylcholine binds to and results in increased activity of [CHRNB2 protein binds to CHRNA2 protein]]; Tubocurarine inhibits the reaction [Acetylcholine binds to and results in increased activity of [CHRNB2 protein binds to CHRNA3 protein]]; Urethane promotes the reaction [Acetylcholine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] acetylcholine affects binding to Chrnb2 protein; acetylcholine competes with [Epibatidine binds to Chrnb2 protein] |
CTD RGD |
PMID:7808438 PMID:11517245 PMID:11711029 PMID:11812690 PMID:12130716 PMID:12604691 PMID:12754307 PMID:14645658 PMID:15733544 PMID:15885267 PMID:16931985 PMID:16981889 PMID:18385335 PMID:19046356 PMID:19252481 PMID:19619141 PMID:20132834 PMID:20861069 PMID:21538459 PMID:21905680 PMID:22547355 PMID:22750351 PMID:25459289 PMID:34628512 PMID:15016836 More...
|
RGD:2303194 |
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Chrnb4 |
cholinergic receptor nicotinic beta 4 subunit |
multiple interactions |
ISO EXP |
1-Butanol affects the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]; 1-Propanol promotes the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]; 2-butanol affects the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]; 2-Propanol promotes the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]; 4-nonylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]; 4-nonylphenol promotes the reaction [Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]]; 4-octylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]; Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]; Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]; Acetylcholine results in increased activity of [CHRNB4 protein binds to CHRNA2 protein]; Acetylcholine results in increased activity of [CHRNB4 protein binds to CHRNA3 protein]; Acetylcholine results in increased activity of [CHRNB4 protein binds to CHRNA4 protein]; Atracurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]]; bisphenol A inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]; bisphenol A promotes the reaction [Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]]; cisatracurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]]; crotonyl alcohol inhibits the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]; Diethylstilbestrol inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]; Diethylstilbestrol promotes the reaction [Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]]; Estradiol inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]; Estradiol promotes the reaction [Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]]; Ethinyl Estradiol inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]; Ethinyl Estradiol inhibits the reaction [Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]]; isobutyl alcohol affects the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]; Mivacurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]]; n-pentanol inhibits the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]; Pancuronium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]]; Rocuronium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]]; Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA3 protein binds to CHRNB4 protein]]; tert-Butyl Alcohol inhibits the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]; Tubocurarine inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]]; Vecuronium Bromide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]] [Mercuric Chloride co-treated with Acetylcholine] affects the activity of [CHRNA3 protein binds to CHRNB4 protein]; [Mercuric Chloride co-treated with Acetylcholine] affects the activity of [CHRNA4 protein binds to CHRNB4 protein]; Acetylcholine binds to and results in increased activity of [CHRNB4 protein binds to CHRNA2 protein]; Acetylcholine binds to and results in increased activity of [CHRNB4 protein binds to CHRNA3 protein]; Tubocurarine promotes the reaction [Acetylcholine binds to and results in increased activity of [CHRNB4 protein binds to CHRNA2 protein]]; Tubocurarine promotes the reaction [Acetylcholine binds to and results in increased activity of [CHRNB4 protein binds to CHRNA3 protein]] |
CTD |
PMID:7808438 PMID:9454827 PMID:11711029 PMID:11821649 PMID:12130716 PMID:16931985 PMID:34628512 More...
|
|
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
|
|
G |
Chrnd |
cholinergic receptor nicotinic delta subunit |
multiple interactions |
ISO EXP |
Acetylcholine binds to and results in increased activity of [CHRNA1 protein binds to CHRNA1 protein binds to CHRNB1 protein binds to CHRND protein binds to CHRNE protein]; Acetylcholine binds to and results in increased activity of [CHRNA1 protein binds to CHRNA1 protein binds to CHRNB1 protein binds to CHRNG protein binds to CHRND protein]; Acetylcholine results in increased activity of [CHRNA1 protein binds to CHRNB1 protein binds to CHRNE protein binds to CHRND protein] |
CTD |
PMID:16931985 PMID:22461452 |
|
NCBI chr 9:87,862,417...87,870,833
Ensembl chr 9:87,862,407...87,870,833
|
|
G |
Chrne |
cholinergic receptor nicotinic epsilon subunit |
multiple interactions |
ISO EXP |
Acetylcholine binds to and results in increased activity of [CHRNA1 protein binds to CHRNA1 protein binds to CHRNB1 protein binds to CHRND protein binds to CHRNE protein]; Acetylcholine results in increased activity of [CHRNA1 protein binds to CHRNB1 protein binds to CHRNE protein binds to CHRND protein] |
CTD |
PMID:16931985 PMID:22461452 |
|
NCBI chr10:55,331,211...55,339,923
Ensembl chr10:55,331,212...55,335,530
|
|
G |
Chrng |
cholinergic receptor nicotinic gamma subunit |
multiple interactions |
EXP ISO |
Acetylcholine binds to and results in increased activity of [CHRNA1 protein binds to CHRNA1 protein binds to CHRNB1 protein binds to CHRNG protein binds to CHRND protein] |
CTD |
PMID:22461452 |
|
NCBI chr 9:87,878,085...87,884,193
Ensembl chr 9:87,878,085...87,914,482
|
|
G |
Crh |
corticotropin releasing hormone |
increases expression |
EXP |
Acetylcholine results in increased expression of CRH mRNA |
CTD |
PMID:7588217 |
|
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Csf2 |
colony stimulating factor 2 |
increases secretion |
ISO |
Acetylcholine results in increased secretion of CSF2 protein |
CTD |
PMID:9606035 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions |
ISO |
CYBB gene mutant form inhibits the reaction [Nitroglycerin results in decreased susceptibility to Acetylcholine] |
CTD |
PMID:18522491 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions decreases response to substance |
EXP |
acetovanillone inhibits the reaction [EDN1 protein results in decreased susceptibility to Acetylcholine]; Catechin inhibits the reaction [EDN1 protein results in decreased susceptibility to Acetylcholine]; Polyphenols inhibits the reaction [EDN1 protein results in decreased susceptibility to Acetylcholine] |
CTD |
PMID:20977430 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Epo |
erythropoietin |
multiple interactions increases response to substance |
ISO |
EPO protein inhibits the reaction [GCH1 gene mutant form results in decreased susceptibility to Acetylcholine] EPO protein results in increased susceptibility to Acetylcholine |
CTD |
PMID:25490417 |
|
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
ESR1 protein affects the susceptibility to [Lipopolysaccharides co-treated with Acetylcholine]; ESR1 protein affects the susceptibility to [Lipopolysaccharides co-treated with Phenylephrine co-treated with Acetylcholine] |
CTD |
PMID:17158209 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Fbn1 |
fibrillin 1 |
multiple interactions |
ISO |
FBN1 protein affects the susceptibility to [Acetylcholine co-treated with Indomethacin] |
CTD |
PMID:17641673 |
|
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
|
|
G |
Fkbp1b |
FKBP prolyl isomerase 1B |
multiple interactions |
ISO |
FKBP1B gene mutant form inhibits the reaction [Acetylcholine affects the localization of and affects the abundance of Calcium]; Ryanodine inhibits the reaction [FKBP1B gene mutant form inhibits the reaction [Acetylcholine affects the localization of and affects the abundance of Calcium]] |
CTD |
PMID:17261647 |
|
NCBI chr 6:27,832,128...27,850,600
Ensembl chr 6:27,838,802...27,848,653
|
|
G |
Gch1 |
GTP cyclohydrolase 1 |
multiple interactions decreases response to substance |
EXP ISO |
[2,4-diaminohypoxanthine results in decreased activity of GCH1 protein] which affects the susceptibility to Acetylcholine EPO protein inhibits the reaction [GCH1 gene mutant form results in decreased susceptibility to Acetylcholine] |
CTD |
PMID:12855421 PMID:25490417 |
|
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
decreases response to substance |
ISO |
GCLC promoter SNP results in decreased susceptibility to Acetylcholine |
CTD |
PMID:12598062 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
affects response to substance |
ISO |
GCLM gene SNP affects the susceptibility to Acetylcholine |
CTD |
PMID:12975258 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
decreases response to substance |
ISO |
GPX1 gene mutant form results in decreased susceptibility to Acetylcholine |
CTD |
PMID:24296279 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Hmox1 |
heme oxygenase 1 |
affects response to substance multiple interactions |
EXP |
HMOX1 protein affects the susceptibility to Acetylcholine [chromium mesoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [Desoxycorticosterone Acetate results in decreased susceptibility to Acetylcholine] |
CTD |
PMID:14693679 PMID:16309587 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases secretion |
ISO |
[IL1B protein co-treated with APP protein] results in increased secretion of Acetylcholine; IL1B protein inhibits the reaction [APP protein results in decreased secretion of Acetylcholine] IL1B protein results in increased secretion of Acetylcholine |
CTD |
PMID:16122837 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
affects response to substance |
ISO |
IL1RN protein affects the susceptibility to Acetylcholine |
CTD |
PMID:10487780 |
|
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il5 |
interleukin 5 |
increases response to substance |
ISO |
IL5 protein results in increased susceptibility to Acetylcholine |
CTD |
PMID:11897983 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il5ra |
interleukin 5 receptor subunit alpha |
increases response to substance affects response to substance |
ISO |
IL5RA protein results in increased susceptibility to Acetylcholine IL5RA protein affects the susceptibility to Acetylcholine |
CTD |
PMID:10487780 PMID:10848907 PMID:11897983 |
|
NCBI chr 4:139,630,652...139,664,593
Ensembl chr 4:139,632,066...139,668,544
|
|
G |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
affects response to substance |
ISO |
KCNJ5 protein affects the susceptibility to Acetylcholine |
CTD |
PMID:26831068 |
|
NCBI chr 8:30,724,923...30,753,083
Ensembl chr 8:30,724,925...30,753,518
|
|
G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
multiple interactions |
EXP |
ABCC8 protein inhibits the reaction [Acetylcholine promotes the reaction [KCNJ8 protein results in increased transport of Potassium]]; Acetylcholine promotes the reaction [KCNJ8 protein results in increased transport of Potassium] |
CTD |
PMID:15894309 |
|
NCBI chr 4:175,508,908...175,515,829
Ensembl chr 4:175,508,912...175,515,603
|
|
G |
Kcnma1 |
potassium calcium-activated channel subfamily M alpha 1 |
affects response to substance |
EXP |
KCNMA1 protein affects the susceptibility to Acetylcholine |
CTD |
PMID:22226998 |
|
NCBI chr15:302,480...1,007,675
Ensembl chr15:302,214...1,001,198
|
|
G |
Lepr |
leptin receptor |
multiple interactions decreases response to substance |
ISO |
acetovanillone inhibits the reaction [LEPR gene mutant form results in decreased susceptibility to Acetylcholine]; resveratrol inhibits the reaction [LEPR gene mutant form results in decreased susceptibility to Acetylcholine]; tempol inhibits the reaction [LEPR gene mutant form results in decreased susceptibility to Acetylcholine]; TNF gene mutant form affects the reaction [LEPR gene mutant form results in decreased susceptibility to Acetylcholine] |
CTD |
PMID:19478208 |
|
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Lpl |
lipoprotein lipase |
affects response to substance |
ISO |
LPL protein affects the susceptibility to Acetylcholine |
CTD |
PMID:11786490 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Lynx1 |
Ly6/neurotoxin 1 |
multiple interactions |
EXP |
LYNX1 protein promotes the reaction [Acetylcholine results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]] |
CTD |
PMID:19619141 |
|
NCBI chr 7:106,632,800...106,638,003
Ensembl chr 7:106,632,797...106,638,023
|
|
G |
Lypd1 |
Ly6/Plaur domain containing 1 |
multiple interactions |
EXP |
LYPD1 protein promotes the reaction [Acetylcholine results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]] |
CTD |
PMID:19619141 |
|
NCBI chr13:37,326,459...37,368,515
Ensembl chr13:37,326,464...37,368,493
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
affects response to substance |
ISO |
MMP9 protein affects the susceptibility to Acetylcholine |
CTD |
PMID:16979597 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions |
ISO |
NCF1 gene mutant form inhibits the reaction [Nitroglycerin results in decreased susceptibility to Acetylcholine] |
CTD |
PMID:18522491 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Acetylcholine] |
CTD |
PMID:11498454 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
affects response to substance increases response to substance multiple interactions increases phosphorylation |
ISO EXP |
NOS3 protein affects the susceptibility to Acetylcholine NOS3 protein results in increased susceptibility to Acetylcholine AICA ribonucleotide inhibits the reaction [Palmitic Acid inhibits the reaction [Acetylcholine results in increased phosphorylation of NOS3 protein]]; Metformin inhibits the reaction [Palmitic Acid inhibits the reaction [Acetylcholine results in increased phosphorylation of NOS3 protein]]; NOS3 protein results in increased susceptibility to [Acetylcholine co-treated with Phenylephrine]; Palmitic Acid inhibits the reaction [Acetylcholine results in increased phosphorylation of NOS3 protein]; resveratrol inhibits the reaction [Palmitic Acid inhibits the reaction [Acetylcholine results in increased phosphorylation of NOS3 protein]]; Salicylic Acid inhibits the reaction [Palmitic Acid inhibits the reaction [Acetylcholine results in increased phosphorylation of NOS3 protein]] |
CTD |
PMID:10954898 PMID:15381055 PMID:17403420 PMID:25108154 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Pink1 |
PTEN induced kinase 1 |
multiple interactions |
ISO |
Acetylcholine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 protein] |
CTD |
PMID:34547296 |
|
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
|
|
G |
Pkd1 |
polycystin 1, transient receptor potential channel interacting |
affects response to substance |
ISO |
PKD1 protein affects the susceptibility to Acetylcholine |
CTD |
PMID:18679710 |
|
NCBI chr10:13,573,779...13,621,138
Ensembl chr10:13,573,021...13,621,128
|
|
G |
Pomc |
proopiomelanocortin |
increases expression multiple interactions |
EXP |
Acetylcholine results in increased expression of POMC mRNA; Acetylcholine results in increased expression of POMC protein Atropine inhibits the reaction [Acetylcholine results in increased expression of POMC protein]; Pentobarbital inhibits the reaction [Acetylcholine results in increased expression of POMC protein] |
CTD |
PMID:7588217 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Ppp1r14a |
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
increases phosphorylation multiple interactions |
EXP |
Acetylcholine results in increased phosphorylation of PPP1R14A protein Beclomethasone inhibits the reaction [Acetylcholine results in increased phosphorylation of PPP1R14A protein]; Prednisolone inhibits the reaction [Acetylcholine results in increased phosphorylation of PPP1R14A protein] |
CTD |
PMID:18577381 |
|
NCBI chr 1:84,583,127...84,590,743
Ensembl chr 1:84,586,627...84,590,671
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
multiple interactions |
ISO |
Acetylcholine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PRKN protein] |
CTD |
PMID:34547296 |
|
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
|
|
G |
Rhoa |
ras homolog family member A |
multiple interactions |
EXP |
[[Antigens, Bacterial co-treated with Allergens] results in increased expression of and results in increased activity of RHOA protein] which results in increased susceptibility to Acetylcholine; Beclomethasone inhibits the reaction [[[Antigens, Bacterial co-treated with Allergens] results in increased expression of and results in increased activity of RHOA protein] which results in increased susceptibility to Acetylcholine]; Prednisolone inhibits the reaction [[[Antigens, Bacterial co-treated with Allergens] results in increased expression of and results in increased activity of RHOA protein] which results in increased susceptibility to Acetylcholine] |
CTD |
PMID:18391481 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Senp2 |
SUMO specific peptidase 2 |
affects localization |
ISO |
SENP2 protein affects the localization of Acetylcholine |
CTD |
PMID:34509475 |
|
NCBI chr11:78,981,429...79,018,274
Ensembl chr11:78,981,432...79,018,238
|
|
G |
Sigmar1 |
sigma non-opioid intracellular receptor 1 |
multiple interactions |
EXP |
[1-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-3,4-dihydro-5-methoxy-2(1H)-quinolinone binds to and results in increased activity of SIGMAR1 protein] which results in increased secretion of Acetylcholine; [N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride binds to and results in decreased activity of SIGMAR1 protein] inhibits the reaction [1-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-3,4-dihydro-5-methoxy-2(1H)-quinolinone results in increased secretion of Acetylcholine] |
CTD |
PMID:11907181 |
|
NCBI chr 5:56,904,155...56,907,012
Ensembl chr 5:56,904,159...56,907,017
|
|
G |
Sirt1 |
sirtuin 1 |
affects response to substance |
EXP |
SIRT1 protein affects the susceptibility to Acetylcholine |
CTD |
PMID:23422569 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc17a8 |
solute carrier family 17 member 8 |
affects secretion |
ISO |
SLC17A8 protein affects the secretion of Acetylcholine |
CTD |
PMID:18278042 |
|
NCBI chr 7:23,994,212...24,049,498
Ensembl chr 7:23,994,217...24,048,079
|
|
G |
Slurp1 |
secreted Ly6/Plaur domain containing 1 |
multiple interactions increases abundance |
ISO |
methyllycaconitine inhibits the reaction [SLURP1 protein results in increased abundance of Acetylcholine] |
CTD |
PMID:24365495 |
|
NCBI chr 7:106,611,949...106,613,365
Ensembl chr 7:106,611,949...106,613,365
|
|
G |
Sod1 |
superoxide dismutase 1 |
affects activity |
EXP |
Acetylcholine affects the activity of SOD1 protein |
CTD |
PMID:9024144 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
affects response to substance multiple interactions |
ISO |
SOD2 protein affects the susceptibility to Acetylcholine catalase-polyethylene glycol affects the reaction [SOD2 protein affects the susceptibility to Acetylcholine]; Indomethacin affects the reaction [SOD2 protein affects the susceptibility to Acetylcholine]; tempol affects the reaction [SOD2 protein affects the susceptibility to Acetylcholine]; valerylsalicylate affects the reaction [SOD2 protein affects the susceptibility to Acetylcholine] |
CTD |
PMID:20304815 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions |
ISO |
Acetylcholine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of SQSTM1 protein] |
CTD |
PMID:34547296 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Tac1 |
tachykinin, precursor 1 |
multiple interactions affects abundance |
EXP |
Urethane affects the reaction [TAC1 protein affects the abundance of Acetylcholine] |
CTD |
PMID:11020227 |
|
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions increases expression |
EXP |
conotoxin AuIB inhibits the reaction [Acetylcholine results in increased expression of TH mRNA]; conotoxin AuIB inhibits the reaction [imidacloprid promotes the reaction [Acetylcholine results in increased expression of TH mRNA]]; imidacloprid promotes the reaction [Acetylcholine results in increased expression of TH mRNA]; triethyl-(beta-4-stilbenoxyethyl)ammonium inhibits the reaction [Acetylcholine results in increased expression of TH mRNA]; triethyl-(beta-4-stilbenoxyethyl)ammonium inhibits the reaction [imidacloprid promotes the reaction [Acetylcholine results in increased expression of TH mRNA]] |
CTD |
PMID:29246838 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Thrb |
thyroid hormone receptor beta |
affects response to substance |
ISO |
THRB protein affects the susceptibility to Acetylcholine |
CTD |
PMID:17461985 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
TNF gene mutant form affects the reaction [LEPR gene mutant form results in decreased susceptibility to Acetylcholine] |
CTD |
PMID:19478208 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
multiple interactions |
EXP |
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [Acetylcholine promotes the reaction [TRPC6 protein results in increased uptake of Calcium]]; 1-oleoyl-2-acetoyl-sn-glycerol promotes the reaction [Acetylcholine promotes the reaction [TRPC6 protein results in increased uptake of Calcium]]; 2-aminoethyl diphenylborinate inhibits the reaction [Acetylcholine promotes the reaction [TRPC6 protein results in increased uptake of Calcium]]; Acetylcholine promotes the reaction [TRPC6 protein results in increased uptake of Calcium]; Acetylcholine promotes the reaction [TRPC6 protein results in increased uptake of Manganese] |
CTD |
PMID:11535132 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Vim |
vimentin |
multiple interactions |
ISO |
VIM protein affects the susceptibility to [Acetylcholine co-treated with Cyclic GMP co-treated with Indomethacin]; VIM protein affects the susceptibility to [Acetylcholine co-treated with Indomethacin] |
CTD |
PMID:11588525 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|